Factors related to a non-localising technetium 99m sestamibi scan result during parathyroid adenoma imaging in primary hyperparathyroidism

Clin Otolaryngol. 2021 Mar;46(2):357-362. doi: 10.1111/coa.13677. Epub 2020 Dec 28.

Abstract

Objectives: The aim of this study is to investigate factors that are associated with having a non-localising 99m Tc-sestamibi scan.

Design: A retrospective study was performed on patients that underwent parathyroid surgery performed within a single institution between 2001 and 2018.

Setting: Single tertiary centre for parathyroid surgery.

Participants: 230 patients underwent surgery for primary hyperparathyroidism due to a solitary parathyroid adenoma and had preoperative 99m Tc-sestamibi imaging.

Main outcome measures: Variables including age, gender, intra-operative location of parathyroid adenoma, adenoma weight and pre- and postoperative calcium and parathyroid hormone levels were investigated through univariate and multivariate analysis to identify any association with having a non-localising (negative) 99m Tc-sestamibi scan result.

Results: Multivariate analysis identified that right-sided adenomas (P = .038), superior adenomas (P = .042) and a lower preoperative PTH level (P = .034) were all individual factors associated with having a negative 99m Tc-sestamibi scan result. Although the weight of the adenoma was significant on univariate analysis (P = .029), this was not demonstrated on multivariate analysis (P = .422).

Conclusion: Factors that were associated with having non-localising 99m Tc-sestamibi scan were right-sided adenomas, superior adenomas and lower preoperative PTH level. Further large prospective multicentre studies are needed to further evaluate these initial findings.

Keywords: adenoma/diagnostic imaging; adenoma/surgery; calcium/blood; hyperparathyroidism/surgery; parathyroid hormone/blood; parathyroid neoplasms/surgery; technetium tc 99m sestamibi.

MeSH terms

  • Adenoma / diagnostic imaging*
  • Adenoma / surgery*
  • Female
  • Humans
  • Hyperparathyroidism, Primary / diagnostic imaging*
  • Hyperparathyroidism, Primary / surgery*
  • Male
  • Middle Aged
  • Parathyroid Neoplasms / diagnostic imaging*
  • Parathyroid Neoplasms / surgery*
  • Retrospective Studies
  • Technetium Tc 99m Sestamibi

Substances

  • Technetium Tc 99m Sestamibi